Ascentage Pharma Group International
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $233,699 | $156,904 | $156,904 | $78,452 |
Gross Profit | 212,049 | 142,878 | 142,878 | 71,439 |
EBITDA | -514,016 | -528,454 | -528,454 | -264,227 |
EBIT | -553,984 | -566,786 | -566,786 | -283,393 |
Net Income | -590,768 | -568,434 | -568,434 | -284,217 |
Net Change In Cash | 233,699 | 156,904 | 156,904 | 78,452 |
Free Cash Flow | 235,272 | 235,272 | 117,636 | |
Cash | 1,661,454 | 1,236,578 | 1,236,578 | 1,261,211 |
Basic Shares | 341,591 | 312,372 | 312,372 | 312,372 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $980,650 | $221,984 | $209,711 | $27,910 |
Gross Profit | 951,565 | 191,441 | 187,713 | 24,582 |
EBITDA | -237,631 | -743,610 | -835,986 | -915,987 |
EBIT | -330,800 | -836,805 | -883,407 | -933,170 |
Net Income | -405,433 | -925,637 | -882,924 | -782,424 |
Net Change In Cash | 980,650 | 221,984 | 209,711 | 27,910 |
Free Cash Flow | -135,646 | -782,921 | -890,878 | -1,041,308 |
Cash | 1,236,578 | 1,069,296 | 1,475,639 | 1,706,886 |
Basic Shares | 302,062 | 70,574 | 65,917 | 63,653 |
